| Net Cash Provided by (Used in) Operating Activities |
$299,000 |
USD |
-53% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$812,000 |
USD |
-207% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
917,285,149 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,111,000 |
USD |
-298% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$43,892,000 |
USD |
0.77% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,266,000 |
USD |
-124% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$11,240,000 |
USD |
0.03% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$41,551,000 |
USD |
0.75% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$288,388,000 |
USD |
0.05% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$15,000 |
USD |
-17% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$81,000 |
USD |
-1.2% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$31,000 |
USD |
-26% |
Q3 2025 |
Q3 2025 |